Pharmacotherapy and Pharmaceutical Care

University of Groningen > Faculty of Science and Engineering > Faculty Board FSE > FSE Research > Groningen Research Institute of Pharmacy > Pharmacotherapy and Pharmaceutical Care

  1. 2021
  2. 2020
  3. van der Schans, J., Hak, E., Postma, M., Breuning, L., Brouwers, J. R. B. J., Ditters, K., Jansen, P. A. F., Kok, R. M., Maring, J. G., van Marum, R., Mulder, H., Nanninga, J., Voshaar, R. C. O., Risselada, A. J., Vleugel, L., Stek, M., van Schaik, R. H. N., Berm, E. J. J., & Wilffert, B. (2020). Article Selected to Receive the Mitchell B. Balter Award for 2020. Journal of Clinical Psychopharmacology, 40(5), 443-443. https://doi.org/10.1097/JCP.0000000000001273
  4. Fedorenko, O. Y., Paderina, D. Z., Loonen, A. J. M., Pozhidaev, I., Boiko, A. S., Kornetova, E. G., Bokhan, N. A., Wilffert, B., & Ivanova, S. A. (2020). Association of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia. Human Psychopharmacology, 35(4), [2737]. https://doi.org/10.1002/hup.2737
  5. Pozhidaev, I., Paderina, D. Z., Fedorenko, O. Y., Kornetova, E. G., Semke, A., Loonen, A. J. M., Bokhan, N. A., Wilffert, B., & Ivanova, S. A. (2020). 5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia. Frontiers in Molecular Neuroscience, 13, [63]. https://doi.org/10.3389/fnmol.2020.00063
  6. Geers, L. M., Pozhidaev, I. V., Ivanova, S. A., Freidin, M. B., Schmidt, A. F., Cohen, D., Boiko, A. S., Paderina, D. Z., Fedorenko, O. Y., Semke, A. V., Bokhan, N. A., Wilffert, B., Kosterink, J. G. W., Touw, D. J., & Loonen, A. J. M. (2020). Association between 8 P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemia. British Journal of Clinical Pharmacology, 86(9), 1827-1835. https://doi.org/10.1111/bcp.14288
  7. Losenkov, I. S., Mulder, N. J. V., Levchuk, L. A., Vyalova, N. M., Loonen, A. J. M., Bosker, F. J., Simutkin, G. G., Boiko, A. S., Bokhan, N. A., Wilffert, B., Hak, E., Schmidt, A. F., & Ivanova, S. A. (2020). Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients. Frontiers in Psychiatry, 11, [38]. https://doi.org/10.3389/fpsyt.2020.00038
  8. 2019
  9. Ochi, T., Vyalova, N. M., Losenkov, I. S., Levchuk, L. A., Osmanova, D. Z., Mikhalitskaya, E. V., Loonen, A. J. M., Bosker, F. J., Simutkin, G. G., Bokhan, N. A., Wilffert, B., & Ivanova, S. A. (2019). Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: A prospective inception cohort study in treatment-free patients. Journal of Affective Disorders, 259, 432-439. https://doi.org/10.1016/j.jad.2019.08.058
  10. Ivanova, S. A., Boiko, A. S., Mednova, I. A., Kornetova, E. G., & Loonen, A. J. M. (2019). P.374 Cortisol and DHEAS related to metabolic side effects in patients with schizophrenia. European Neuropsychopharmacology, 29(Supp. 6), S265-S266. https://doi.org/10.1016/j.euroneuro.2019.09.389
  11. Vyalova, N., Ochi, T., Losenkov, I., Levchuk, L., Osmanova, D., Mikhalitskaya, E., Loonen, A. J. M., Bosker, F. J., Simutkin, G., Bokhan, N., Wilffert, B., & Ivanova, S. (2019). P.505 The potential role of BDNF and prolactin genotypes on antidepressant response in depressive patients. European Neuropsychopharmacology, 29(Suppl. 6), S355-S356. https://doi.org/10.1016/j.euroneuro.2019.09.511
  12. van der Schans, J., Hak, E., Postma, M., Breuning, L., Brouwers, J. R. B. J., Ditters, K., Jansen, P. A. F., Kok, R. M., Maring, J. G., van Marum, R., Mulder, H., Nanninga, J., Oude Voshaar, R. C., Risselada, A. J., Vleugel, L., Stek, M., van Schaik, R. H. N., Berm, E. J. J., & Wilffert, B. (2019). Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial). Journal of Clinical Psychopharmacology, 39(6), 583-590. https://doi.org/10.1097/JCP.0000000000001129
  13. Boiko, A. S., Mednova, I. A., Kornetova, E. G., Semke, A. V., Bokhan, N. A., Loonen, A. J. M., & Ivanova, S. A. (2019). Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia. Heliyon, 5(7), [e02033]. https://doi.org/10.1016/j.heliyon.2019.e02033
  14. 2018
  15. 2017
  16. Geers, L. M., Pozhidaev, I. V., Ivanova, S. A., Freidin, M. B., Cohen, D., Boiko, A. S., Osmanova, D. Z., Fedorenko, O. Y., Touw, D. J., Semke, A. V., Wilffert, B., Bokhan, N. A., & Loonen, A. J. M. (2017). Association between P-glycoprotein polymorphisms and antipsychotic drug-induced hyperprolactinemia. European Neuropsychopharmacology, 27(Supplement 4), S956. https://doi.org/10.1016/S0924-977X(17)31689-9
  17. Nuntamool, N., Ngamsamut, N., Vanwong, N., Puangpetch, A., Chamnanphon, M., Hongkaew, Y., Limsila, P., Suthisisang, C., Wilffert, B., & Sukasem, C. (2017). Pharmacogenomics and Efficacy of Risperidone Long-Term Treatment in Thai Autistic Children and Adolescents. Basic & clinical pharmacology & toxicology, 121(4), 316-324. https://doi.org/10.1111/bcpt.12803
  18. Kovačević, S. V., Miljković, B., Ćulafić, M., Kovačević, M., Golubović, B., Jovanović, M., Vučićević, K., & de Gier, J. J. (2017). Evaluation of drug-related problems in older polypharmacy primary care patients. Journal of Evaluation in Clinical Practice, 23(4), 860-865. https://doi.org/10.1111/jep.12737
Previous 1 2 3 4 5 6 7 8 ...23 Next

ID: 32723